Brief: XSpray Pharma Reports Positive Results From A Study With Dasatinib During Omeprazole Treatment

Xspray Pharma publ AB

30/12/2020 12:41

Dec 30 (Reuters) - XSpray Pharma AB (publ)  XSPRAY.ST :
    * XSPRAY PHARMA REPORTS POSITIVE RESULTS FROM A STUDY WITH
DASATINIB DURING OMEPRAZOLE TREATMENT
    * RECEIVED POSITIVE PRELIMINARY RESULTS FROM A
BIOAVAILABILITY
STUDY IN HEALTHY VOLUNTEERS WITH AN IMPROVED HYNAP-DASA VERSION
OF REFERENCE DRUG SPRYCELTM
    * ABSORPTION OF HYNAP-DASA IS NOT DEPENDENT ON GASTRIC PH
LEVEL

Source text for Eikon:  ID:nMFN9gCs9W 
Further company coverage:  XSPRAY.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))